This inventor holds 1 USPTO granted patent. Top assignee: Assia Chemical Industries Ltd.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Khaled Haj Ali: Pioneering Innovations in Pharmaceutical Chemistry
Introduction
Khaled Haj Ali, an accomplished inventor based in Tayibe, Israel, has made significant contributions to the field of pharmaceutical chemistry. His innovative work has led to the development of novel solid-state forms of Valbenazine, enhancing the potential therapeutic applications of this important medication.
Latest Patents
Khaled Haj Ali holds a patent for "Salts and solid state forms of Valbenazine, including Valbenazine ditosylate, processes for preparation thereof, pharmaceutical compositions thereof, and uses thereof." This groundbreaking invention demonstrates his expertise in the formulation of pharmaceuticals, providing valuable insights into the preparation and application of Valbenazine in therapeutic settings.
Career Highlights
As a member of Assia Chemical Industries Ltd., Khaled has been instrumental in advancing the company’s research and development initiatives. His dedication to innovation in pharmaceutical sciences has positioned him as a leading figure in the industry, contributing to the company’s reputation for excellence in chemical manufacturing and formulation.
Collaborations
Khaled collaborates closely with talented colleagues such as Marina Yarovoy and Jonathan Enav. Together, they form a dynamic team that drives the company’s research projects forward, fostering an environment where creativity and scientific inquiry thrive.
Conclusion
Khaled Haj Ali’s contributions to patent innovation and pharmaceutical development underscore the importance of collaborative efforts in advancing medical science. His work continues to have a meaningful impact on both the scientific community and the future of therapeutic applications for Valbenazine.